|
PRPS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.775400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.103000E-03 |
| Normal-vs-Stage2 |
8.14860000000195E-05 |
| Normal-vs-Stage3 |
4.962500E-03 |
| Normal-vs-Stage4 |
3.950000E-02 |
| Stage1-vs-Stage2 |
1.259830E-02 |
| Stage1-vs-Stage3 |
5.421000E-01 |
| Stage1-vs-Stage4 |
7.700000E-01 |
| Stage2-vs-Stage3 |
3.757900E-02 |
| Stage2-vs-Stage4 |
1.712000E-02 |
| Stage3-vs-Stage4 |
4.804600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023640E-03 |
| Normal-vs-AfricanAmerican |
2.599800E-01 |
| Normal-vs-Asian |
1.822000E-01 |
| Caucasian-vs-AfricanAmerican |
5.441600E-01 |
| Caucasian-vs-Asian |
3.437400E-01 |
| AfricanAmerican-vs-Asian |
9.313000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.719200E-03 |
| Normal-vs-Female |
8.042100E-04 |
| Male-vs-Female |
8.972800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.927600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.006640E-04 |
| Normal-vs-Age(61-80Yrs) |
2.819400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.978600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.658200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.463800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.698600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.192400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.190000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.840200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.257800E-01 |
| Classical-VS-Follicular |
5.81299453017436E-11 |
| Classical-VS-Other |
4.040200E-01 |
| Classical-VS-Normal |
1.098750E-01 |
| Tall-VS-Follicular |
6.31569999999249E-05 |
| Tall-VS-Other |
3.335200E-01 |
| Tall-VS-Normal |
3.834800E-01 |
| Follicular-VS-Other |
1.995610E-01 |
| Follicular-VS-Normal |
9.08130015631059E-10 |
| Other-VS-Normal |
1.196190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37039999995137E-06 |
| Normal-vs-N1 |
4.615400E-03 |
| N0-vs-N1 |
4.509000E-01 |
|
|
